DOI:
10.1055/s-00000036
Laryngo-Rhino-Otologie
LinksClose Window
References
Dolzhikova IV, Zubkova OV, Tukhvatulin AI. et al.
Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: An open phase I/II trial in healthy adults in Russia.
Human vaccines & immunotherapeutics 2017;
13: 613-620
DOI: 10.1080/21645515.2016.1238535.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.